ROCKWELL MEDICAL, INC. Inventory, Work in Process, Net of Reserves
ROCKWELL MEDICAL, INC. (RMTI) had Inventory, Work in Process, Net of Reserves of $418.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Inventory › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryWorkInProcessNetOfReserves · last filed 2026-08-13
- 2026-06-30: Inventory, Work in Process, Net of Reserves $418.00K.
- 2026-03-31: Inventory, Work in Process, Net of Reserves $241.00K.
- 2025-12-31: Inventory, Work in Process, Net of Reserves $199.00K.
- 2025-09-30: Inventory, Work in Process, Net of Reserves $278.00K.
| Period end | Inventory, Work in Process, Net of Reserves | Inventory, Work in Process, Net of Reserves as first filed |
|---|---|---|
| 2026-06-30 | $418.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $241.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $199.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $278.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $242.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $330.00K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $367.00K 10-K · filed 2026-03-26 | |
| 2024-09-30 | $319.00K 10-Q · filed 2024-11-12 | |
| 2023-12-31 | $351.00K 10-K · filed 2025-03-20 | |
| 2023-09-30 | $337.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $411.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $504.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $351.00K 10-K · filed 2024-03-21 | |
| 2022-09-30 | $336.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $285.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $408.00K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $201.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $266.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $265.00K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $312.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $172.00K 10-K · filed 2022-04-08 | |
| 2020-09-30 | $329.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $303.55K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $291.70K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $185.00K 10-K · filed 2021-03-31 | $184.38K 10-K · filed 2020-03-17 |
| 2019-09-30 | $209.94K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $244.74K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $240.40K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $256.13K 10-K · filed 2020-03-17 | |
| 2018-09-30 | $203.50K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $219.55K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $124.53K 10-Q/A · filed 2018-08-14 | |
| 2017-12-31 | $212.50K 10-K · filed 2019-03-18 | |
| 2017-09-30 | $231.38K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $234.33K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $91.55K 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $86.45K 10-K · filed 2018-03-15 | |
| 2016-09-30 | $145.09K 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $143.82K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $190.98K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $165.91K 10-K · filed 2017-03-15 | |
| 2015-09-30 | $187.39K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $146.83K 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $212.50K 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $197.11K 10-K · filed 2016-02-29 | |
| 2014-09-30 | $207.43K 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $199.31K 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $231.94K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $254.71K 10-K · filed 2015-03-03 | |
| 2013-09-30 | $215.61K 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $226.10K 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $170.46K 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $179.92K 10-K · filed 2014-03-07 | |
| 2011-12-31 | $171.84K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |